Featured in the endpoints news- the factors driving a rapid evolution of gene & cell therapy and…

APAC is the fast growing region globally for cell & gene therapy trials representing

Novotech Presented with Cell & Gene Excellence Award 2022 at 6th Cell & Gene Therapy World Asia…

Novotech, the leading Asia Pacific biotech specialist CRO, has been awarded the Cell & Gene T

Asia Pacific Cell & Gene Research Growing 50% Faster than ROW

Novotech, the leading Asia Pacific focused biotech specialist CRO and recipient of the

Global Report: Robust Phase 1 Trial Growth Across Asia Pacific

Novotech, the leading Asia Pacific centred biotech CRO, has published a new global report on Phas

Novotech and Endpoints Present “Evolution of Cell & Gene Therapy in China: The Case for Universal…

Sydney - Novotech, the leading Asia Pacific biotech specialist CRO with expanded

Novotech Platinum Sponsor at ChinaTrials13 Summit Shanghai 2021

Sydney - Novotech, a leading biotech specialist CRO in the Asia-Pacific region,

Experts Share Insights on Evolving Global Vaccine Landscape Including mRNA Trends

Novotech, the leading Asia Pacific centred biotech CRO with extensive experience in vaccine trial

Novotech Receives “Best Biologics CRO Award 2022” at Korea Bioprocessing Excellence Awards 2022

Seoul, South Korea - Novotech, the leading Asia Pacific biotech specialist CRO w

Novotech Chairs BioCentury Summit Workshop on How to Build and Finance an East-West MRCT Strategy

Novotech has recently been benchmarked as a top 10 CRO among the world’s leading CROs, is a final

CEO End of year announcement December 2022

Novotech Selected as Scrip Awards Finalist for Best Full-Service CRO

Novotech, the leading Asia Pacific biotech specialist CRO, joins a prestigious group of global CR

Novotech Team at BIO Europe to Share Benefits of Expanded Global Operations

Singapore - Novotech, the leading Asia Pacific centred biotech CRO will be at BI

The Biotech Landscape Webinar: Market Trends, Priorities, Predictions, and Pathways to FDA Approval

Novotech, the leading Asia Pacific biotech specialist CRO, and Endpoints News present a webinar f

Novotech Awarded the Asia Pacific CRO of the Year 2022 for Best Practices in Clinical Trials

Novotech, the leading Asia Pacific biotech specialist CRO, has been awarded the Frost & Sulli

Novotech Acquires US-based Drug Development Consulting Firm, CBR International - Expands Drug…

Novotech, the leading Asia Pacific centered biotech CRO today announced the acquisition of CBR In

Novotech Publishes Multi-Specific Monoclonal Antibodies Global Clinical Trial Landscape Report

Singapore - Novotech, the leading Asia Pacific centred biotech CRO has published

Novotech Acquires European CRO – Strengthens Global Operations

Novotech announced today the acquisition of EastHORN, a European CRO with clinical, medical and r

Clinical Research Opportunities in China and the Path to USFDA Approval - Whitepaper

Novotech, the leading Asia Pacific biotech specialist CRO, and GlobalData have published the late

Novotech is Gold Sponsor at Biotech Showcase 2023

Novotech, the Asia Pacific centered biotech specialist CRO is proud to be Gold Sponsor at Biotech

Novotech Team Joins BIO Partnering at JPM 2023

Novotech, the Asia Pacific centered biotech specialist CRO, will attend JPM 2023 and experts from

Novotech India Recognised as “Best Workplaces for Women 2022” by Global Work Standards Authority

Novotech, the leading Asia Pacific biotech specialist CRO, has again received “Best Workplace” ce

Data Shows 50% of New Trials Have Sites in Asia Pacific

Novotech, the Asia Pacific centered biotech specialist CRO said the latest industry research publ

Novotech Sponsors “The Next Big Thing in Cancer Care” Webinar - CAR-T, Precision Oncology, AI and…

Novotech, the Asia Pacific centered biotech specialist CRO, presents “The Next Big Thing in Cance

Novotech at ESMO Congress 2022 - New Data Shows 100% Oncology Trials Growth in APAC

Meet the team at Booth #409 

Novotech Sponsors Pre-ASCO China Summit Expert Panels on Early Phase Oncology Trials and…

Sydney - Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded it

Four key strategies for Western biotechs to expedite drug development in China

Home to a booming clinical trials market, China presents a huge opportunity for clinical innovati

Novotech Partners with National Taiwan University Hospital (NTUH) to Support Biotech Clinical…

Taipei, Taiwan – Asia-Pacific specialist CRO Novotech announced today that leadi

Starting Your Clinical Journey With The End In Mind – The Value Of A Drug Development Plan

Establishing an intelligent clinical development program pathway from the start is vital for clar

Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in…

Sydney - Novotech, the leading Asia Pacific biotech specialist CRO which has rec